When Hippocrates first described cancer around 400 B.C., he referred to the disease's telltale tumors as "karkinos"—the Greek word for crab. The "Father of Western Medicine" likely noted that cancer's creeping projections ...
Sep 13, 2016
0
104
An international team including Rice University researchers has discovered a way to fight the overexpression of a protein associated with the proliferation of breast cancer.
Sep 12, 2016
0
131
Individual cells within a tumor are not all the same. This may sound like a modern medical truism, but it wasn't very long ago that oncologists assumed that taking a single biopsy from a patient's tumor would be an accurate ...
Sep 9, 2016
0
3724
Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.
Sep 7, 2016
0
0
A prominent physician scientist supported by the National Foundation of Cancer Research (NFCR), Dr. Daniel Haber, and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression ...
Sep 6, 2016
0
2
Scientists from the United States have made an important step toward eliminating cancer recurrence by combining immunotherapy with chemotherapy. Specifically, they found that chemotherapy alone leads to two types of dormant ...
Sep 1, 2016
0
11
A team of Case Western Reserve University School of Medicine cancer researchers has uncovered one way certain tumors resist vital medication.
Aug 11, 2016
0
10
Mutations in the BRCA1 gene are one of the most common risk factors for breast and ovarian cancers. Although tumors that harbor BRCA1 mutations initially respond well to cancer treatments, many tumors eventually become less ...
Jul 25, 2016
0
82
Estrogens are responsible for the survival and proliferation of tumor cells in 70% of all breast cancer cases. The most frequently used treatment to fight this variety of tumors relies on anti-estrogens such as tamoxifen. ...
Jun 20, 2016
0
5
At the American Society for Clinical Oncology (ASCO) Annual Meeting 2016, researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a ...
Jun 3, 2016
0
3304
